| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |